Sunrise is a Sanofi initiative that connects world-class science and emerging platforms with committed resources and expert capabilities from Sanofi. Our aim is to turn basic scientific discoveries from outstanding scientists and clinicians into new medicines and treatment paradigms for patients in need.
We seek out transformative, often high-risk, opportunities to drive innovation by partnering with external life science pioneers and the venture capital community. Our strategy enables a move from the traditional in-license model to a new paradigm of company co-creation and early-stage investing in people and ideas that could transform health care.
Through Sunrise, Sanofi is changing the R&D model and implementing open innovation at its finest. Sunrise works globally across all therapeutic areas, focusing on high-value projects. We forge long-term partnerships with the best, wherever that may be.